PRESENTATION | MALES | FEMALES | TOTAL |
Age At Presentation (Mean ± SD years) | 38 ± 12.53 | 34 ± 14.61 | 37.23 ± 12.89 |
Proteinuria | 15 (50%) | 03 (10%) | 18 (60%) |
Microscopic Hematuria | 05 (16.67%) | 01 (3.33%) | 06 (20%) |
Pedal Oedema | 02 (6.67%) | 02 (6.67%) | 04 (13.33%) |
Anasarca | 02 (6.67%) | 02 (6.67%) | 04 (13.33%) |
Accelerated Hypertension | 03 (10%) | - | 03 (10%) |
Oliguria | 02 (6.67%) | - | 02 (6.67%) |
Visual Blurring | 01 (3.33%) | - | 01 (3.33%) |
Systolic BP (Mean ± SD mm Hg) | 155.04 ± 17.70 | 150 ± 13.66 | 153.87 ± 16.77 |
Diastolic BP (Mean ± SD mm Hg) | 93.65 ± 8.83 | 92 ± 6.85 | 93.38 ± 8.40 |
Serum Creatinine (Mean ± SD mg/dl) | 1.0 ± 0.17 | 0.92 ± 0.17 | 0.99 ± 0.16 |
Serum Albumin (Mean ± SD gm/dl) | 2.5 ± 0.75 | 2.56 ± 0.87 | 2.51 ± 0.76 |
Nephrotic Range Proteinuria | 11 (36.67%) | 04 (13.33%) | 15 (50%) |
Massive Proteinuria | 03 (10%) | 02 (6.67%) | 05 (16.67%) |
Urine Albumin By Dipstick:- | |||
4+ | 02 (6.67%) | 02 (6.67%) | 04 (13.33%) |
3+ | 06 (20%) | 02 (6.67%) | 08 (26.67%) |
2+ | 08 (26.67%) | 03 (10%) | 11 (36.67%) |
1+ | 05 (16.67%) | 01 (3.33%) | 07 (23.34%) |
Trace | 01 (3.33%) | - | 01 (3.33%) |